CXCL8 and obesity due to melanocortin 4 receptor deficiency: It may be a potential candidate in combating obesity (Uusitupa et al., 2020) and could reduce proinflammatory factor secretion (IL-8), enhance intestinal barrier function (Xu et al., 2022).